Financial Impact of Anastomotic Leakage in Colorectal Surgery.


Journal

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
ISSN: 1873-4626
Titre abrégé: J Gastrointest Surg
Pays: United States
ID NLM: 9706084

Informations de publication

Date de publication:
03 2019
Historique:
received: 12 06 2018
accepted: 26 08 2018
pubmed: 15 9 2018
medline: 9 6 2020
entrez: 15 9 2018
Statut: ppublish

Résumé

Anastomotic leakage after colorectal surgery is a complication that requires additional treatments strongly affecting the economic outcomes. We evaluated the use of resources and the economic burden associated with anastomotic leaks following colorectal surgery. Between January 2015 and December 2016, we retrospectively evaluated patients who underwent colorectal surgery with primary anastomosis. We compared the medical resource utilization and the DRG-based reimbursement of cases with uncomplicated surgery and cases complicated by anastomotic leakage. Of the 95 patients included in the study, 87 (92%) presented an uneventful postoperative course and 8 patients (8%) developed an anastomotic leakage requiring surgery. The statistical analysis showed no significant differences in terms of demographics, risks factor, and operative results, except the length of hospital stay (9.7 vs. 29.1 days, p < 0.01). The cost for 87 uncomplicated cases was 1,535,297 EUR (average cost of 17,647 EUR), whereas the cost of the 8 patients with anastomotic leakage was 575,822 EUR (average cost of 71,978 EUR) (p < 0.01). For each patient, the hospital had 542 EUR profit in the uncomplicated group and a 12,181 EUR loss in the anastomotic leakage group (p < 0.01). The multiple R-squared line regression analysis showed that factors independently related to costs were age (p = 0.05) and length of hospital stay (p = 0.01). In terms of economic impact, the occurrence of an anastomotic leakage has a large negative influence on medical resource utilization, so that, despite the complication-related increase of DRG-reimbursement, every complicated case represents a financial burden for the hospital.

Sections du résumé

BACKGROUND
Anastomotic leakage after colorectal surgery is a complication that requires additional treatments strongly affecting the economic outcomes. We evaluated the use of resources and the economic burden associated with anastomotic leaks following colorectal surgery.
METHODS
Between January 2015 and December 2016, we retrospectively evaluated patients who underwent colorectal surgery with primary anastomosis. We compared the medical resource utilization and the DRG-based reimbursement of cases with uncomplicated surgery and cases complicated by anastomotic leakage.
RESULTS
Of the 95 patients included in the study, 87 (92%) presented an uneventful postoperative course and 8 patients (8%) developed an anastomotic leakage requiring surgery. The statistical analysis showed no significant differences in terms of demographics, risks factor, and operative results, except the length of hospital stay (9.7 vs. 29.1 days, p < 0.01). The cost for 87 uncomplicated cases was 1,535,297 EUR (average cost of 17,647 EUR), whereas the cost of the 8 patients with anastomotic leakage was 575,822 EUR (average cost of 71,978 EUR) (p < 0.01). For each patient, the hospital had 542 EUR profit in the uncomplicated group and a 12,181 EUR loss in the anastomotic leakage group (p < 0.01). The multiple R-squared line regression analysis showed that factors independently related to costs were age (p = 0.05) and length of hospital stay (p = 0.01).
CONCLUSIONS
In terms of economic impact, the occurrence of an anastomotic leakage has a large negative influence on medical resource utilization, so that, despite the complication-related increase of DRG-reimbursement, every complicated case represents a financial burden for the hospital.

Identifiants

pubmed: 30215201
doi: 10.1007/s11605-018-3954-z
pii: 10.1007/s11605-018-3954-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

580-586

Références

J Am Coll Surg. 2009 Feb;208(2):269-78
pubmed: 19228539
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Health Res Policy Syst. 2010 Oct 16;8:31
pubmed: 20950481
Health Aff (Millwood). 2013 Apr;32(4):713-23
pubmed: 23569051
World J Gastroenterol. 2013 Apr 21;19(15):2293-7
pubmed: 23613621
BMC Health Serv Res. 2013 May 22;13:186
pubmed: 23692862
BMJ. 2013 Jun 07;346:f3197
pubmed: 23747967
Eur J Surg Oncol. 2013 Oct;39(10):1063-70
pubmed: 23871573
Perioper Med (Lond). 2014 Mar 07;3(1):1
pubmed: 24606631
J Gastrointest Surg. 2014 Jun;18(6):1176-85
pubmed: 24671472
Swiss Med Wkly. 2015 Feb 06;145:w14097
pubmed: 25659119
Health Serv Res Manag Epidemiol. 2016 May 12;3:2333392816647892
pubmed: 28462278

Auteurs

Davide La Regina (D)

Department of Surgery, EOC-Ospedale Regionale di Bellinzona e Valli, Ospedale San Giovanni, via Ospedale, Bellinzona, Switzerland.

Matteo Di Giuseppe (M)

Department of Surgery, EOC-Ospedale Regionale di Bellinzona e Valli, Ospedale San Giovanni, via Ospedale, Bellinzona, Switzerland.

Massimo Lucchelli (M)

Medical Controller, EOC-Ospedale Regionale di Bellinzona e Valli, Bellinzona, Switzerland.

Andrea Saporito (A)

Division of Anesthesiology, EOC-Ospedale Regionale di Bellinzona e Valli, Bellinzona, Switzerland.

Luigi Boni (L)

Department of Surgery, Fondazione IRCCS, Ospedale Maggiore Policlinico, Milan, Italy.

Christopher Efthymiou (C)

Cardiothoracic Surgery, Glenfield Hospital, Groby Road, Leicester, UK.

Stefano Cafarotti (S)

Department of Surgery, EOC-Ospedale Regionale di Bellinzona e Valli, Ospedale San Giovanni, via Ospedale, Bellinzona, Switzerland.

Michele Marengo (M)

Department of Surgery, EOC-Ospedale Regionale di Bellinzona e Valli, Ospedale San Giovanni, via Ospedale, Bellinzona, Switzerland.

Francesco Mongelli (F)

Department of Surgery, EOC-Ospedale Regionale di Bellinzona e Valli, Ospedale San Giovanni, via Ospedale, Bellinzona, Switzerland. francesco.mongelli@mail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH